Strength
1 mg/1
Manufacturer
AvPAKNDC
50268071813
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SIROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA201578On Market Since
4/23/2018
Pharmacological Classes
Price Statistics
The NADAC for SIROLIMUS 1 MG TABLET has been published 403 times since Oct 10, 2018, and over the history we have for it it has declined 89.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9516 per EA |
|---|---|
| All-time high | $9.0309 (Dec 12, 2018) |
| All-time low | $0.9516 (Jun 17, 2026) |
| 52-week high | $2.0873 |
| 52-week low | $0.9516 |
| Median price | $4.7235 |
| Average price | $4.6729 |
| Largest weekly change | -38.5% (Nov 20, 2024) |
| Weeks tracked | 403 |
| Tracking since | Oct 10, 2018 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SIROLIMUS 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SIROLIMUS 1 MG TABLET, manufactured by AvPAK, is $0.9516 per EA (NDC 50268071813), effective Jun 24, 2026.
How has the price of SIROLIMUS 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for SIROLIMUS 1 MG TABLET has declined 89.1%. It has been tracked across 403 weekly CMS publications since Oct 10, 2018.
What are the highest and lowest recorded NADAC prices for SIROLIMUS 1 MG TABLET?
Since Oct 10, 2018, the NADAC for SIROLIMUS 1 MG TABLET has ranged from a low of $0.9516 (Jun 17, 2026) to a high of $9.0309 (Dec 12, 2018), with a median of $4.7235 per EA.
Are there cheaper alternatives to SIROLIMUS 1 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as SIROLIMUS 1 MG TABLET, but none are currently priced below it.
Who manufactures SIROLIMUS 1 MG TABLET?
SIROLIMUS 1 MG TABLET (NDC 50268071813) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification